Poster Abstract Session:
51. Antimicrobial Stewardship: Interventions to Improve Outcomes
Thursday, October 4, 2018: 12:30 PM-1:45 PM
Room: S Poster Hall

Tracks: Adult ID, Epidemiology and Infection Control, Investigative ID, Pediatric ID

The Effect of Two Antibiotic Stewardship Interventions in a Telemedicine Practice
Ian Tong, MD; Kristin Dean, MD; Daniel Park, MPH; James Thompson, BS; Lily Yan, MD; Cindy Liu, MD, PhD, MPH; Rana Hamdy, MD, MPH, MSCE
Public Health Can Play a Role Implementing a Successful Outpatient Antimicrobial Stewardship in Primary and Urgent Care
Kelsey OYong, MPH; James A. McKinnell, MD; Chelsea Foo, MPH; Stacy Hartmann, MPH; Dawn Terashita, MD, MPH
Implementation of a Prospective, Pharmacist-Led Methicillin-Resistant Staphylococcus aureus Nasal PCR Screening Pilot Protocol to Reduce Overutilization of Vancomycin
Jessica Miller, Pharm.D.; Erik LaChance, Pharm.D.; Jill Starykowicz, Pharm.D., BCCCP; Sarah M. Wieczorkiewicz, Pharm.D., BCPS AQ-ID
Pharmacist-Led Antimicrobial Prompting During Interdisciplinary Team Rounds As a Novel Antimicrobial Stewardship Intervention
Alisha Skinner, MD; Heather Young, MD; Kati Shihadeh, PharmD; Bryan Knepper, MPH, MS, CIC; Timothy C. Jenkins, MD
  • Pharmacist Prompting Poster.pdf (758.3 kB)
  • 199
    The Urgent Need for Urgent Care Antimicrobial Stewardship: Evaluating Prescribing and Patient Outcomes Associated with a Pharmacist-led Stewardship Program
    Lauren Fay, PharmD; Lauren Wolf, PharmD, BCPS; Kasey Brandt, PharmD, BCPS; G. Robert Deyoung, PharmD, BCPS; Adam Anderson, MD, FACEP; Nnaemeka Egwuatu, MD, MPH; Lisa Dumkow, PharmD, BCPS
  • ID Week Poster_Fay_Final1.pdf (443.3 kB)
  • 201
    Outcomes of an Antibiotic Stewardship Team at an Academic Medical Center: 11 Years of Experience
    Susan Kline, MD, MPH, FSHEA, FIDSA; Kimberly Boeser, PharmD, BCPS AQ-ID; Pamela Phelps, Pharm D; Samantha Saunders, MPH; Kari Gand, MPH, BBA; Jeana Houseman, MHSA, DLM(ASCP), CIC; Shawnda Johnson, BA
    Implementation and Three-Year Results of Antimicrobial Stewardship Program in a Three Hospital Community Health System
    Nikunj Vyas, PharmD, BCPS; Cindy Hou, DO, MA, MBA, FACOI; Marianne Kraemer, RN, MPA, ED.M., CENP, CCRN; David Condoluci, DO, MACOI; Deborah Cunningham, MT HHS, BA; Sungwook Kim, Ph.D.
  • ID Week ASP Poster 2018.pdf (709.6 kB)
  • 203
    Impact of an Infectious Diseases Fellow-Led Antimicrobial Stewardship Initiative in a Medical/Surgical ICU
    Ann Palmer, MD; Ulysses Wu, MD; Prashant Grover, MD; Dora Wiskirchen, PharmD
  • Slide1.jpg (130.2 kB)
  • 204
    Impact of Education and Data Feedback Interventions on Outpatient Prescribing for Urinary Tract Infections
    Jason Funaro, PharmD; Rebekah W. Moehring, MD, MPH; Siyun Yang, MS; Hui-Jie Lee, PhD; Christina Sarubbi, PharmD; Deverick J. Anderson, MD, MPH, FIDSA, FSHEA; Rebekah Wrenn, PharmD
  • Funaro_IDWeekPoster_Final.pdf (308.7 kB)
  • 205
    Reduction of Antibiotic Prescribing within a Veterans Affairs Emergency Department through Peer Comparison
    Rameez Phulpoto, MD; Nathan R. Shively, MD; Deanna J. Buehrle, PharmD; Cornelius J. Clancy, M.D.; Brooke K. Decker, MD, CIC
    Respiratory Viral Testing is Associated with Lower Frequency of Antibiotic Prescribing for Acute Upper Respiratory Infections at a Large Ambulatory Cancer Center
    Elizabeth M. Krantz, MS; Erica Stohs, MD, MPH; Ania Sweet, PharmD; Jacqlynn Zier, BA; Sara Marquis, MPH; John Klaassen, BA; Steven Pergam, MD, MPH, FIDSA; Catherine Liu, MD, FIDSA
    Impact of Educational Interventions on Antibiotic Prescribing for Acute Upper Respiratory Tract Infections in the Ambulatory Care Setting
    Kaitlyn Craddock, PharmD; Suzanne Molino, PharmD, BCPS; Paul M. Stranges, PharmD, BCPS, BCACP; Katie J. Suda, PharmD, M.S.; Thomas Kannampallil, PhD; Jonathan Radosta, MD; John Hickner, MD; Nancy L. Shapiro, PharmD, BCACP; Susan C. Bleasdale, MD; Alan E. Gross, PharmD, BCPS-AQ ID
    Trends in Antibiotic Prescribing for Acute Respiratory Tract Infections and Implementation of a Provider-Directed Intervention Within the Veterans Affairs Healthcare System (VA)
    Karl Madaras-Kelly, PharmD, MPH; Hayli Hruza, MPH; Benjamin Pontefract, PharmD; Barbara Jones, MD; Makoto Jones, MD, MS; Yiwen Yao, MStat; McKenna Nevers, MS; Jian Ying, PhD; Ben Haaland, PhD; Chad Kay, Pharm. D; Melissa Christopher, PharmD; Matthew Samore, MD, FSHEA
    Impact of a risk-based CAP prescribing guideline paired with antimicrobial stewardship to improve antibiotic prescribing for patients at low risk for drug resistant pathogens
    Caroline Cruce, PharmD; Michael Postelnick, RPh BCPS AQ ID; David Martin, PharmD, BCPS; Sarah Sutton, MD; Richard G. Wunderink, MD; Teresa Zembower, MD, MPH, FIDSA; Marc H. Scheetz, PharmD, MSc, BCPS AQ-ID; Nathaniel J. Rhodes, PharmD, MSc, BCPS
    Improved Antimicrobial Utilization in the Emergency Department: Impact of a Point of Care Polymerase Chain Reaction Test for The Rapid Detection Influenza
    Jonathan Williams, MD; Nicholas Mercuro, PharmD; Amit Vahia, M.D., M.P.H.; Hira Rizvi, MD; Mujtaba Hameed, BS*; Odaliz Abreu-Lanfranco, MD; Pallavi Bhargava, MD; Linoj Samuel, PhD., D(ABMM); George Alangaden, MD, FIDSA
  • Influenza PCR Poster.pdf (320.9 kB)
  • 212
    Impact of a Prospective Audit and Feedback Antimicrobial Stewardship Initiative on Pneumonia Treatment at an Academic Teaching Hospital
    Jeffrey C. Pearson, PharmD; Monica V. Mahoney, PharmD, BCPS-AQ ID; Graham M. Snyder, MD, SM; Howard S. Gold, MD, FIDSA; Parth V. Patel, BSN, RN; Christopher McCoy, PharmD, BCPS-AQ ID
    Multi-centered Evaluation of an Acute Respiratory Tract Infection Audit-Feedback Intervention: Impact on Antibiotic Prescribing Rates and Patient Outcomes
    Karl Madaras-Kelly, PharmD, MPH; Hayli Hruza, MPH; Benjamin Pontefract, PharmD; Robert Mckie, MD; Christopher Hostler, MD, MPH; Mary Townsend, PharmD, AAHIVP; Emily M. Potter, PharmD; Emily Spivak, MD, MHS; Sarah Hall, MD; Matthew Goetz, MD; McKenna Nevers, MS; Jian Ying, PhD; Ben Haaland, PhD; Katherine Fleming-Dutra, MD; Matthew Samore, MD, FSHEA
    Antimicrobial Usage and Outcomes following Laboratory Suppression of Antimicrobial Susceptibility Results for Pseudomonas aeruginosa in Sputum Cultures
    Kwee Chin Liew, MBBS / Bachelor of Medical Sciences (1st Class Honors); Oliver Evans, MBBS; Erica Wales, MD; Stuart Bond, PhD; Peter Newton, MBBS, FRCPA; Spiros Miyakis, MD, PhD, FRACP
  • PSEUDOMONAS.pdf (66.9 kB)
  • 216
    Step-down Therapy with Oral Fluoroquinolones vs. Oral Beta-Lactams for Hospitalized Adult Patients with Community-Acquired Pneumonia: A Multi-Hospital Cohort Study
    Lindsay Petty, M.D.; Twisha S. Patel, PharmD, BCPS; Anna Conlon, PhD; Daniel Nielsen, MS; Valerie Vaughn, MD, MSc; Keith Kaye, MD, MPH; Anurag Malani, MD, FIDSA; Danielle Osterholzer, MD; Rama Thyagarajan, MD; Scott Flanders, M.D.; Tejal Gandhi, MD
    Bang for the Buck: Lessons Learned from An Ambulatory Stewardship Pilot to Reduce Excess Antibiotic Prescribing for Adult Upper Respiratory Infections
    Jaimie Mittal, MD; Kelsie Cowman, MPH; Abel Infante, -; Paul Meissner, MSPH; Asif Ansari, MD; Priya Nori, MD; Belinda Ostrowsky, MD, MPH, FIDSA, FSHEA
    IV to PO Conversion of Antimicrobials: Small Intervention, Big Impact
    Wenjing Wei, PharmD; Norman Mang, PharmD; Jessica Ortwine, PharmD; Kristin Alvarez, PharmD; Bonnie Prokesch, MD
    Taking Off with Antimicrobial Intervention Rounds (AIR): Successes of a Pilot Stewardship Service at a Tertiary-Care VA Medical Center
    Ukwen Akpoji, Pharm.D., BCPS; Roberto Viau Colindres, M.D.; Robin Jump, M.D., Ph.D.; Usha Stiefel, M.D.
    Save the Quinolones! Impact of a Non-Restrictive Fluoroquinolone Reduction Initiative on Antibiotic Resistance at an Urban Teaching Hospital
    Steven Smoke, PharmD; Slava Plotkin, PharmD; Neeki Patel, PharmD; Adriana Grigoriu, MD; Maria DeVivo, PharmD
  • 221_IDWeek 2018 Poster.pdf (938.2 kB)
  • 223
    Impact of Different Stewardship Strategies Applied to a Single Antibiotic Over Time
    Katherine Lusardi, PharmD, BCPS-AQ ID; Ryan Dare, MD, MS
    Cost Analysis of a Significant Decrease in Vancomycin Use as a Result of an Antimicrobial Stewardship Intervention
    Hayley Hodgson, PharmD; Paul O'Donnell, PharmD; Sarah Won, MD, MPH; Sheila K. Wang, PharmD, BCPS
    An Emergency Department Antimicrobial Stewardship Intervention to Improve Antibiotic Selection and Duration for Skin and Soft Tissue Infections in Adult and Pediatric Outpatients
    Larissa May, MD, MSPH; Dan Tancredi, PhD; Benjamin Mooso, MS; Megan Nguyen, PharmD; Susan Ondak, MD; Chance Anderson, MS; Jennifer Briggs, PharmD; Linh Luong, BS; Loren G. Miller, MD, MPH
    Impact of Early Alert to Antimicrobial Stewardship Interventions with the Prospective Audit and Feedback Strategy
    Sarah Si Lin Tang, BSc (Pharm) (Hons); Lun Yi Tan, BSc; Daphne Yah Chieh Yii, BPharm; Andrea L. Kwa, PharmD; Piotr Chlebicki, MBBS
  • Bizlive poster.pdf (591.3 kB)
  • 229
    The Role of Antimicrobial Stewardship Program on Appropriate Use, Dose and Duration of Vancomycin Treatment
    Olga Kaplun, MD; Melinda Monteforte, PharmD; Samad Tirmizi, PharmD; Mersema Abate, MD; George Psevdos Jr., MD; Roderick Go, DO
  • Vancomycin IDSA.pdf (623.3 kB)
  • 230
    Characterization of Antibiotic Timeout Program Strategies Across The United States
    Doaa Aljefri, PharmD, MSc; Caroline Cruce, PharmD; Patrick Kinn, PharmD, MPH; Kristi Kuper, PharmD, BCPS; Lucas T Schulz, PharmD, BCPS (AQ-ID); Erin K. McCreary, PharmD, BCPS; Michael Postelnick, RPh BCPS AQ ID
    Facilitating the Everyday Steward: Impact of Mandatory Antimicrobial Indication/Duration and a 48 Hour Time Out
    Ann Wirtz, PharmD; Alaina Burns, PharmD; Brian R. Lee, MPH, PhD; Tammy Frank, RPh, CPHIMS; Laura Fitzmaurice, MD; Richard Ogden, PharmD, MBA, BCPS; Brian O'Neal, PharmD, MS, FASHP; Jennifer Goldman, MD, MS
    Do Antibiotic Timeouts Improve Antibiotic Utilization?
    Patrick Kinn, PharmD, MPH; Michael Postelnick, RPh BCPS AQ ID; Kristi Kuper, PharmD, BCPS; Amanda Gibson, PharmD; Amy Pakyz, PharmD, MS, PhD; Lucas T Schulz, PharmD, BCPS (AQ-ID)
    Evaluation of an Antimicrobial Time-Out on Antimicrobial Utilization at a Large Health System
    Steven Richardson, PharmD; Elizabeth Neuner, PharmD, BCPS (AQ-ID); Vasilios Athans, PharmD, BCPS; Pavithra Srinivas, PharmD, BCPS; Jill Wesolowski, PharmD; Steven Gordon, MD; Thomas Fraser, MD
    Improving antimicrobial prescribing and rate of infectious diseases consult utilizing a best-practice alert and targeted education for Staphylococcus aureus bacteremia
    Katherine Yang, PharmD; Tejal Gandhi, MD; Chris Zimmerman, PharmD; Robert Chang, MD, FACP, SHFM; Jerod Nagel, PharmD, BCPS
  • ID Week SAB BPA Poster.pdf (5.6 MB)
  • 235
    If Symptoms Aren’t Described, Antibiotics Aren’t Prescribed: Implementation of a Multifaceted Toolkit Targeting Overtreatment of Asymptomatic Bacteriuria across a Large Health-system
    Julie E. Williamson, PharmD; Andrea Y. Logan, PharmD; M. Sean Boger, MD, PharmD; Steven Jarrett, PharmD; Stephanie J. Irausquin, PhD; Lisa Davidson, MD
    The Impact of Earlier Intervention by an Antimicrobial Stewardship Team on Appropriate Antimicrobial Therapy for Specific Antimicrobial Agents
    Daiki Hagiwara, PhD; Keisuke Sato, PhD; Mitsuhiro Kamada, PhD; Norihiro Moriwaki, PhD; Takafumi Nakano, PhD; Shouichi Shiotsuka, PhD; Hidetoshi Kamimura, PhD; Atsushi Togawa, MD, PhD; Yasushi Takamatsu, MD, PhD; Tohru Takata, MD, PhD
  • IDWeek2018 Takata.pdf (1.1 MB)
  • 237
    Antibiotic Assessment at Discharge-Room for Stewardship Intervention
    Prakash Balasubramanian, MD; Paul Lata, PharmD; Meredith Peters, MD; Christopher Crnich, MD, PhD; Susanne Barnett, PharmD
  • MAD VA Outpt rx.pdf (971.3 kB)
  • 238
    Sharing unit specific stewardship metrics with front-line providers to improve antibiotic prescribing
    Nicholas J Mercuro, PharmD; Rachel Kenney, PharmD; Raghavendra Vemulapalli, MD; Mariam Costandi, MD; Berta Rezik, MD; Charles T Makowski, PharmD; Susan L Davis, PharmD
    Implementation of a Vertical Antimicrobial Stewardship Intervention for Patients Colonized with Clostridium difficile
    Sara Revolinski, PharmD, BCPS; Christina Tran, PharmD; Angela Huang, PharmD, BCPS-AQ ID; Njeri Wainaina, MD; L. Silvia Munoz-Price, MD, PhD
    Evaluating the Effectiveness of Antimicrobial Restriction at an Academic Medical Center
    Andrew Kirk, BS; Kimberly Lee, PharmD; John Markley, DO; Amy Pakyz, PharmD, MS, PhD; Gonzalo Bearman, MD, MPH, FSHEA; Michelle Doll, MD, MPH; Michael Stevens, MD, MPH
    Prioritization of Antibiotic Administration for STAT Orders in the Septic Patient: A Retrospective Analysis
    Stefanie Lam, MSc, PharmD; Zong Heng Shi, PharmD candidate; Nikki Kampouris, BPharm, MSc; Renaud Roy, PharmD, MSc.; Marty Teltscher, MDCM, FRCPC
    Impact of Antibiotic Susceptibility Reporting on Broad-Spectrum Antibiotic Use in Serratia and Morganella Bacteremia
    Wendy Hui Wen Ng, BSc (Pharm) (Hons); Joy Yong, BSc (Pharm) (Hons), BCPS; Ka Lip Chew, MBBS, B. Med. Sci. FRCPath; Janice Li, MClin Pharm, BCPS
  • IDWeek_244_final_printed.pdf (682.8 kB)
  • CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.